Intrinsic Value of S&P & Nasdaq Contact Us

INVO Bioscience, Inc. INVO NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
28/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — INVO

INVO Bioscience, Inc. (INVO) has a market capitalization of $3.25M and trades at $0.83. The 52-week range is 0.63-3.5.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-3,019.48, annual revenue of $6.53B.

The stock has a beta of 1.44, operates in the Healthcare sector.

Trading Data
Current Price$0.83
52-Week Range0.63-3.5
Volume124.02K
Avg Volume (30D)1.15M
Market Cap$3.25M
Beta (1Y)1.44
Company
IPO Date2020-11-02
Employees25
CEOSteven M. Shum
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS44984F4019
CUSIP44984F302
Income (Latest Year)
Revenue$6.53B
Gross Profit$2.87B
EBITDA$-9.51B
Operating Income$-8.13B
Net Income$-9.35B
EPS$-3,019.48
EPS Diluted$-3,019.48
Shares Outstanding$3.1M
Balance Sheet (Latest Year)
Total Assets$46.45B
Current Assets$1.32B
Cash & ST Investments$741.4M
Total Liabilities$26.24B
Total Debt$10.78B
Net Debt$10.03B
Valuation Ratios
P/E Ratio-0
P/S Ratio0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message